Association of ABCB1/MDR1 polymorphisms in patients with glucocorticoid-induced osteonecrosis of the femoral head: Evidence for a meta-analysis

Gene
Zifei ZhouZhengdong Cai

Abstract

Glucocorticoid-induced osteonecrosis of the femoral head (GC-induced ONFH) is a rebarbative disease affecting people from all ages, especially young adults, and often leads to severe joint pain and limitations on physical activity. Numerous studies have reported that ABCB1 polymorphisms are associated with GC-induced ONFH, but the results are inconclusive, partially because the sample size of published studies is relatively small. Therefore, we performed a meta-analysis including seven case-control studies to estimate such association. Published literature from Medline, Embase, and CNKI were searched for eligible publications. Pooled odds ratio (OR) together with their 95% confidence (CI) was calculated using a fixed effect model or random effect model. The meta-analysis was performed in accordance to PRISMA Statement Criteria. The ABCB1 3435T allele reduces the GC-induced ONFH risk based on the evidence from the co-dominant model (CT vs. CC, OR=0.73, 95% CI: 0.53-1.00; TT vs. CC, OR=0.43, 95% CI: 0.26-0.69), dominant model (CT+TT vs. CC, OR=0.64, 95% CI: 0.48-0.87), allele contract model, (T vs. C, OR=0.68, 95% CI: 0.54-0.84), and recessive model (TT vs. CC+CT, OR=0.52, 95% CI: 0.34-0.81). Similarly, the ABCB1 2677T/A allele r...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Oct 2, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary V RellingSue C Kaste
Sep 6, 2005·Pharmacogenetics and Genomics·Danxin WangWolfgang Sadée
May 3, 2006·The Journal of Bone and Joint Surgery. American Volume·Michael A MontDavid S Hungerford
Aug 13, 2008·Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association·Masaaki KuribayashiToshikazu Kubo
Mar 17, 2009·Biochimica Et Biophysica Acta·King Leung Fung, Michael M Gottesman
Feb 23, 2010·International Journal of Surgery·David MoherUNKNOWN PRISMA Group
Jul 2, 2010·Calcified Tissue International·Ning HanZhiyong Zhang
Sep 21, 2012·Canadian Journal of Surgery. Journal Canadien De Chirurgie·Wael A RahmanBassam A Masri
Jun 3, 2014·Systematic Reviews·Elizabeth StovoldAnna Noel-Storr
Aug 12, 2014·TheScientificWorldJournal·Rainer BeckmannWolf Drescher

❮ Previous
Next ❯

Citations

Apr 23, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Xiaodong ZhaoAli Zhang
Oct 18, 2018·International Orthopaedics·Tracy WangChantal Séguin
Oct 30, 2020·Journal of Orthopaedic Surgery and Research·Xiangnan RenXuefeng Yu
Mar 17, 2021·Journal of Korean Medical Science·Quanjun CuiDewei Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.